Evidence map›Paper›PMID 38693758›Full record

ArticleClinical and experimental immunology2024

Impact on in-depth immunophenotyping of delay to peripheral blood processing.

Lauren E Higdon, Sheila Scheiding, Anna M Kus, Noha Lim, S Alice Long, Mark S Anderson, Alice E Wiedeman

Open access · hybridAbstract read
In one paragraph

Article in Clinical and experimental immunology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.2field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Lauren E HigdonBiomarker and Discovery Research, Immune Tolerance Network, San Francisco, CA, USA.ORCID 0000-0002-6470-6155
Sheila ScheidingCenter for Translational Immunology, Benaroya Research Institute, Seattle, WA, USA.ORCID 0000-0001-5466-9568
Anna M KusCenter for Translational Immunology, Benaroya Research Institute, Seattle, WA, USA.ORCID 0000-0001-6330-4114
Noha LimBiomarker and Discovery Research, Immune Tolerance Network, San Francisco, CA, USA.
S Alice LongCenter for Translational Immunology, Benaroya Research Institute, Seattle, WA, USA.ORCID 0000-0002-0281-1240
Mark S AndersonBiomarker and Discovery Research, Immune Tolerance Network, San Francisco, CA, USA.
Alice E WiedemanCenter for Translational Immunology, Benaroya Research Institute, Seattle, WA, USA.ORCID 0000-0001-7329-7288
Benaroya Research InstituteImmune Tolerance Network · US

Funding

Immune Tolerance Network UM1 2023 SupplementUM1AI109565 · NIAID · BENAROYA RESEARCH INST AT VIRGINIA MASON · PI Mark S Anderson, Jane Hoyt Buckner · 2014 to 2026
$451.6M
National Institute of Allergy and Infectious DiseasesNIAID NIH HHS UM1 AI109565NIH HHS UM1AI109565
6 · The paper itself

Abstract

Peripheral blood mononuclear cell (PBMC) immunophenotyping is crucial in tracking activation, disease state, and response to therapy in human subjects. Many studies require the shipping of blood from clinical sites to a laboratory for processing to PBMC, which can lead to delays that impact sample quality. We used an extensive cytometry by time-of-flight (CyTOF) immunophenotyping panel to analyze the impacts of delays to processing and distinct storage conditions on cell composition and quality of PBMC from seven adults across a range of ages, including two with rheumatoid arthritis. Two or more days of delay to processing resulted in extensive red blood cell contamination and increased variability of cell counts. While total memory and naïve B- and T-cell populations were maintained, 4-day delays reduced the frequencies of monocytes. Variation across all immune subsets increased with delays of up to 7 days in processing. Unbiased clustering analysis to define more granular subsets confirmed changes in PBMC composition, including decreases of classical and non-classical monocytes, basophils, plasmacytoid dendritic cells, and follicular helper T cells, with each subset impacted at a distinct time of delay. Expression of activation markers and chemokine receptors changed by Day 2, with differential impacts across subsets and markers. Our data support existing recommendations to process PBMC within 36 h of collection but provide guidance on appropriate immunophenotyping experiments with longer delays.

Indexed as

ImmunophenotypingLeukocytes, MononuclearAdultAgedBlood PreservationB-LymphocytesFemaleFlow CytometryHumansMaleMiddle AgedMonocytesTime FactorsCyTOFdelayed processingimmunophenotypingmonocytesperipheral blood mononuclear cells

Identifiers

PMID38693758
PMCPMC11239563
OpenAlexW4396592141

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.